Antimicrobial Peptides and Their Mimetics: Promising Candidates of Next‐Generation Therapeutic Agents Combating Multidrug‐Resistant Bacteria DOI Open Access
Tianyi Zhang, Qiao Jin,

Jian Ji

и другие.

Advanced Biology, Год журнала: 2025, Номер unknown

Опубликована: Фев. 6, 2025

Abstract The increasing morbidity and mortality caused by multidrug‐resistant bacteria alerts human beings to the fact that conventional antibiotics are no longer reliable effective alternatives imperatively needed. Owing wide range of sources, diverse structures, unique mode action, antimicrobial peptides have been highly anticipated extensively studied in recent years. Besides, integration artificial intelligence helps researchers gain access vast unexplored chemical space, which opens more opportunities for optimization design novel structures. Moreover, Due advances chemistry synthetic biology, also begun focus on potential mimetics peptides. In this review, a comprehensive discussion about natural synthesized as well their is made, so provide summary field inspire follow‐up research.

Язык: Английский

In vitro antimicrobial activity of the novel antimicrobial peptide mytimacin-4 and its influence on the microbial community and quality of pork during refrigerated storage DOI
Bin Dong,

Yijie Wang,

Guirong Cui

и другие.

Food Control, Год журнала: 2024, Номер 163, С. 110486 - 110486

Опубликована: Март 30, 2024

Язык: Английский

Процитировано

10

Synergistic collaboration between AMPs and non-direct antimicrobial cationic peptides DOI Creative Commons
Zifan Ye,

Lei Fu,

Shuangyu Li

и другие.

Nature Communications, Год журнала: 2024, Номер 15(1)

Опубликована: Авг. 25, 2024

Non-direct antimicrobial cationic peptides (NDACPs) are components of the animal innate immune system. But their functions and association with (AMPs) incompletely understood. Here, we reveal a synergistic interaction between AMP AW1 NDACP AW2, which co-expressed in frog Amolops wuyiensis. AW2 enhances antibacterial activity both vitro vivo, while mitigating development bacterial resistance eradicating biofilms. synergistically damage membranes, facilitating cellular uptake intracellular target genomic DNA. Simultaneously, they trigger generation ROS bacteria, contributing to cell death upon reaching threshold level. Moreover, demonstrate that this effect AMPs NDACPs is prevalent across diverse species. These findings unveil robust previously unknown correlation as widespread defense strategy animals. Antimicrobial non-direct secreted response invasive pathogens. Ye et al show there these two types expressed from amphibian

Язык: Английский

Процитировано

10

Non‐canonical amino acid bioincorporation into antimicrobial peptides and its challenges DOI Creative Commons
George Enninful, Rajesh Kuppusamy, Elvis K. Tiburu

и другие.

Journal of Peptide Science, Год журнала: 2024, Номер 30(6)

Опубликована: Янв. 23, 2024

The rise of antimicrobial resistance and multi‐drug resistant pathogens has necessitated explorations for novel antibiotic agents as the discovery conventional antibiotics is becoming economically less viable technically more challenging biopharma. Antimicrobial peptides (AMPs) have emerged a promising alternative because their particular mode action, broad spectrum difficulty that microbes in to them. AMPs bacitracin, gramicidin, polymyxins daptomycin are currently used clinically. However, susceptibility proteolytic degradation, toxicity profile, complexities large‐scale manufacture hindered development. To improve stability, methods such integrating non‐canonical amino acids (ncAAs) into peptide sequence been adopted, which also improves potency action. benefits ncAA incorporation made possible by solid‐phase synthesis. this method not always suitable commercial production poor yield, scale‐up difficulties, its non‐‘green’ nature. Bioincorporation integration an emerging field geared towards tackling challenges synthesis green, cheaper, scalable commercialisation AMPs. This review focusses on bioincorporation ncAAs; some associated with outlined, notes given how overcome these challenges. particularly addressing two key challenges: AMP cytotoxicity microbial cell factories uptake ncAAs unfavourable Overcoming will draw us closer greater yield environmentally friendly sustainable approach make druggable.

Язык: Английский

Процитировано

9

Machine Learning Accelerates De Novo Design of Antimicrobial Peptides DOI
Kedong Yin, Wen Xu,

Shiming Ren

и другие.

Interdisciplinary Sciences Computational Life Sciences, Год журнала: 2024, Номер 16(2), С. 392 - 403

Опубликована: Фев. 28, 2024

Язык: Английский

Процитировано

9

Antimicrobial Peptides and Their Mimetics: Promising Candidates of Next‐Generation Therapeutic Agents Combating Multidrug‐Resistant Bacteria DOI Open Access
Tianyi Zhang, Qiao Jin,

Jian Ji

и другие.

Advanced Biology, Год журнала: 2025, Номер unknown

Опубликована: Фев. 6, 2025

Abstract The increasing morbidity and mortality caused by multidrug‐resistant bacteria alerts human beings to the fact that conventional antibiotics are no longer reliable effective alternatives imperatively needed. Owing wide range of sources, diverse structures, unique mode action, antimicrobial peptides have been highly anticipated extensively studied in recent years. Besides, integration artificial intelligence helps researchers gain access vast unexplored chemical space, which opens more opportunities for optimization design novel structures. Moreover, Due advances chemistry synthetic biology, also begun focus on potential mimetics peptides. In this review, a comprehensive discussion about natural synthesized as well their is made, so provide summary field inspire follow‐up research.

Язык: Английский

Процитировано

1